{
  "report_rows": [
    {
      "kpi": "Revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$806M vs. cons $804.5M",
      "confidence": "LOW"
    },
    {
      "kpi": "Adjusted diluted EPS",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.94 vs. cons $1.926",
      "confidence": "LOW"
    },
    {
      "kpi": "OCC revenue growth",
      "prediction": "MISS",
      "answer": "pred ~5.1% vs. cons 5.35%",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 revenue",
      "prediction": "UNCHANGED",
      "answer": "guide ~$3.19B-$3.24B vs. cons $3.223B",
      "confidence": "LOW"
    },
    {
      "kpi": "FY2026 adjusted EPS",
      "prediction": "UNCHANGED",
      "answer": "guide ~$7.45-$7.75 vs. cons $7.673",
      "confidence": "LOW"
    },
    {
      "kpi": "Q3/H2 OCC recovery commentary",
      "prediction": "BETTER",
      "answer": "guide ~recovery toward 6%-8% vs. Q3 cons 5.35%",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -3.0,
  "day1_confidence": "LOW",
  "day5_residual_pct": -4.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 modest H2 de-risking",
  "day5_confidence": "LOW"
}